查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
子宫内膜异位症全球市场规模/份额/行业趋势分析报告，按类型、治疗方法（口服避孕药、GnRH製剂、其他）、分销渠道、地区展望/预测2022-2028
市场调查报告书
商品编码
1219646

子宫内膜异位症全球市场规模/份额/行业趋势分析报告，按类型、治疗方法（口服避孕药、GnRH製剂、其他）、分销渠道、地区展望/预测2022-2028

Global Endometriosis Market Size, Share & Industry Trends Analysis Report By Type, By Treatment (Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 204 Pages | 订单完成后即时交付

价格

子宫内膜异位症的全球市场规模预计将在 2028 年达到 22 亿美元，预测期内復合年增长率为 11.6%。

子宫内膜异位症斑块往往很“粘”，可以将器官连接在一起。 粘连是这些情况的医学术语。 例如，肠子和膀胱可能会“粘”在子宫上。 大的子宫内膜异位斑块可发展成囊肿，在每月月经期间出血。 这种囊肿被称为“巧克力囊肿”，可能会因黑血而肿胀。

在没有正式诊断的情况下，许多子宫内膜异位症患者仅根据症状进行治疗。 在某些情况下，可以通过称为腹腔镜检查的简单程序做出明确诊断。 对于此过程，在腹部做一个小切口（通常为 1.5 厘米或更小），然后通过它插入一个照相机以观察骨盆内部。 可以进行活组织检查（一小部分组织样本）。

COVID-19 影响分析

COVID-19 大流行对子宫内膜异位症市场产生了负面影响，因为它大规模重组了世界各地的医学院和医院，以扩大 COVID-19 患者的医院容量。预计会给 在大流行期间，子宫内膜异位症治疗的发展和发现放缓，但并未停止。 医疗保健提供者只接受紧急病例，并为不太严重的病例提供更多的家庭护理。 此外，生产设施关闭和明胶等原材料短缺严重扰乱了子宫内膜异位症药物的供应链。

市场增长因素

政府努力提高对子宫内膜异位症的认识

在与初级保健机构有良好联繫的三级和二级保健机构中建立高级诊断成像、药物、手术、生育治疗和多学科干预的转诊网络和护理途径。 通过增加工具（如超声和磁共振成像）和药物的可用性，卫生系统可以更好地早期发现和治疗子宫内膜异位症（复方口服避孕药、非甾体镇痛药）、药物、黄体酮类避孕药等。 ). 一些主要政府机构的宣传计划和其他宣传活动将推动市场增长。 预计这将在预测期内进一步推动市场增长。

子宫内膜异位症等妇科疾病发病率增加

子宫内膜异位症是一种类似于子宫内膜的组织生长在子宫外，导致疼痛和不孕的疾病。 据估计，全世界约有 10% 的育龄妇女和青少年（1.9 亿人）患有子宫内膜异位症。 子宫内膜异位症会引起月经、性交、排便、膀胱运动、慢性盆腔不适、胃胀、噁心、疲劳等难以忍受的危及生命的症状，有时还会出现抑郁、焦虑和不孕等症状。它是一种引起疼痛的慢性疾病影响

市场製约因素

目前还没有针对子宫内膜异位症的非侵入性诊断测试。

诊断测试的实用性和有效性主要取决于其对特定疾病的敏感性和特异性。 然而，了解这些措施并将其应用于临床决策有时可能具有挑战性。 阳性或阴性测试足以确定患者是否患有疾病的可能性称为阳性预测值 (PPV) 或阴性预测值 (NPV)。 由于缺乏合适和有效的诊断设备，子宫内膜异位症市场预计增长缓慢。

按类型划分的前景

按类型，子宫内膜异位症市场分为浅表腹膜病变、子宫内膜异位症等。 到 2021 年，浅表腹膜病变部分将在子宫内膜异位症市场中占据最高的收入份额。 这是浅表腹膜病变发病率上升以及提高对子宫内膜异位症认识的计划创建的结果。 此外，增加政府对子宫内膜异位症研究的资助正在加速浅表腹膜病变部分的发展。

分销渠道前景

子宫内膜异位症市场按分销渠道分为医院药店、网上药店和零售药店。 2021 年，医院药房部门在子宫内膜异位症市场的收入份额最大。 这是由于医院药房的扩张以及患者对医院作为优质护理提供者的信任度增加。 医院药房市场主要受到子宫内膜异位症治疗替代手术的上升趋势的推动。 医院药师还具有丰富的药物知识，可以帮助子宫内膜异位症患者及其护理人员选择合适的药物。 所有这些因素都在推动该行业的扩张。

治疗景观

子宫内膜异位症市场按治疗方法细分为口服避孕药、促性腺激素释放激素 (GnRH) 製剂等。 2021 年，促性腺激素释放激素 (GnRH) 药物细分市场将在子宫内膜异位症市场中占据显着的收入份额。 它们有片剂、注射剂、注射剂和滴鼻剂。 Orilissa (Elagolix) 由 AbbVie Inc. 製造，是 FDA 批准的第一种缓解疾病相关疼痛的药物。 GnRH 激动剂和拮抗剂应被视为对一线药物耐药的患者的替代药物。

区域展望

按地区分析了北美、欧洲、亚太地区和 LAMEA 的子宫内膜异位症市场。 北美地区在 2021 年的收入份额最大的子宫内膜异位症市场占据主导地位。 这主要是由于需要促性腺激素释放激素（GnRH）药物等额外治疗的子宫内膜异位症患者数量增加、政府对子宫内膜异位症研究的资助增加以及发达国家资本收入大幅增加等。 此外，旨在降低支出水平的复杂报销系统也有助于扩大市场。

内容

第1章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场规模
  • 细分
    • 全球子宫内膜异位症市场，按类型
    • 全球子宫内膜异位症市场，按治疗分类
    • 全球子宫内膜异位症市场，按分销渠道
    • 全球子宫内膜异位症市场，按地区
  • 调查方法

第 2 章市场概述

  • 简介
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场製约因素

第 3 章全球子宫内膜异位症市场：按类型

  • 世界浅表腹膜病变市场：按地区
  • 全球子宫内膜异位症市场：按地区
  • 世界其他地区市场

第 4 章全球子宫内膜异位症市场：按治疗分类

  • 全球口服避孕药市场：按地区
  • 按地区划分的促性腺激素释放激素 (GnRH) 产品的全球市场
  • 其他世界市场：按地区

第 5 章全球子宫内膜异位症市场：按分销渠道

  • 全球住院药房市场：按地区
  • 全球零售药店市场，按地区
  • 全球在线药店市场：按地区

第 6 章全球子宫内膜异位症市场：按地区

  • 北美
    • 北美国家/地区的子宫内膜异位症市场
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲子宫内膜异位症市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 亚太地区按国家/地区划分的子宫内膜异位症市场
      • 中国
      • 日本
      • 印度
      • 韩国
      • 新加坡
      • 马来西亚
      • 其他亚太地区
  • 拉美
    • LAMEA 子宫内膜异位症市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • 其他拉美地区

第7章公司简介

  • Abbott Laboratories
  • Teva Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Consilient Health Limited

The Global Endometriosis Market size is expected to reach $2.2 billion by 2028, rising at a market growth of 11.6% CAGR during the forecast period.

Endometrial-like tissue that arises in unintended places is a typical symptom of endometriosis. The tissue that develops and sheds in the uterus is known as endometrial tissue. The majority of the time, this growth occurs on and around pelvic cavity organs. Similar to the tissue inside the uterus, endometrial tissue undergoes growth, thickening, and attempts at shedding with each menstrual cycle.

The tissue can result in adhesions, tumors, and lesions that set off an inflammatory reaction since it has no way to leave the body. This may result in discomfort and other issues, such as infertility. Over the years, various causes of endometriosis have been proposed. The endometrium is the name for the lining of the uterus. According to one notion, endometrial cells can go from the uterus to the pelvic region. When a patient has a period, they pour backward along the Fallopian tubes and end up there.

Endometriosis patches have a tendency to be "sticky" and can connect organs. Adhesions are the medical word for this. The gut or bladder, for instance, could "stuck" to the uterus. Large endometriosis patches might develop into cysts that bleed every month during menstruation. The cysts are referred to as "chocolate cysts" and might swell up with black blood.

Without a formal diagnosis, many endometriosis patients receive treatment based solely on their symptoms. In some instances, a laparoscopy, a straightforward surgery, is used to provide an authoritative diagnosis. In this operation, a tiny abdominal incision (often less than 1.5cm/0.6 inches) is made, through which a camera is inserted to view the pelvic cavity. Biopsies, or small tissue samples, can be taken.

COVID-19 Impact Analysis

The COVID-19 outbreak is projected to have a negative effect on the endometriosis market due to the massive restructuring of medical schools and hospitals around the world to expand hospital capacity for COVID-19 patients. During the pandemic, the development and discovery of endometriosis treatments slowed but did not stop. Healthcare providers were only accepting emergency cases and suggested home care more to the less important cases. Moreover, the shutdown of production facilities and the lack of raw materials like gelatin significantly interrupted the supply chain for endometriosis medications.

Market Growth Factors

Government efforts to raise endometriosis awareness

Establishing referral networks and care pathways with advanced imaging, pharmaceutical, surgical, fertility, and multidisciplinary interventions at tertiary and secondary centers with good connections to primary healthcare facilities. Increasing the availability of tools (such as ultrasound or magnetic resonance imaging) and medications will help health systems be better equipped to detect and treat endometriosis early (e.g., combined oral contraceptives, non-steroidal analgesics, and progestin-based contraceptives). The market growth will be boosted by numerous significant governmental entities conducting programs and other awareness programs to raise awareness. This would increasingly support the market growth during the projection period.

Increasing incidence of gynecological disorders such as endometriosis

Endometriosis is a condition in which tissue that resembles the uterine lining grows outside of the uterus, resulting in pain and/or infertility. Around 10% (190 million) of women and adolescents of reproductive age suffer from endometriosis worldwide. It is a chronic condition that causes excruciating, life-altering agony during periods, sexual activity, bowel and/or bladder movements, chronic pelvic discomfort, stomach bloating, nausea, exhaustion, and occasionally depression, anxiety, and infertility.

Market Restraining Factors

The absence of non-invasive endometriosis diagnostic tests

A diagnostic test's usefulness and validity are primarily determined by its sensitivity and specificity for a certain ailment. However, it can occasionally be challenging to comprehend and apply these measures to clinical decision-making. The likelihood that a positive or negative test would properly identify whether a patient has the condition is known as the positive predictive value (PPV) or negative predictive value (NPV). The endometriosis market is predicted to experience slow expansion due to the absence of appropriate and efficient diagnosis devices.

Type Outlook

Based on type, the endometriosis market is segmented into superficial peritoneal lesion, endometriomas and others. The superficial peritoneal lesion segment generated the highest revenue share in the endometriosis market in 2021. This is a result of the increase in the incidence of superficial peritoneal lesions and the creation of programs to raise endometriosis awareness. Additionally, a rise in government financing for endometriosis research has accelerated the development of the superficial peritoneal lesion segment.

Distribution Channel Outlook

On the basis of distribution channel, the endometriosis market is categorized into hospital pharmacy, online pharmacy, and retail pharmacy. The hospital pharmacy segment witnessed the largest revenue share in the endometriosis market in 2021. This is due to an expansion in hospital pharmacies and a rise in patients' confidence in hospitals as providers of high-quality care. The hospital pharmacy market is primarily driven by the growing trend of endometriosis therapy as an alternative to surgery. Hospital pharmacists can also help endometriosis patients, and their carers choose the right medications because they are knowledgeable about medications. Such elements all encourage sector expansion.

Treatment Outlook

By treatment, the endometriosis market is bifurcated into oral contraceptives, gonadotropin-releasing hormone (GnRH) medicines and others. The gonadotropin-releasing hormone (GnRH) medicines segment recorded a prominent revenue share in the endometriosis market in 2021. They are available as a tablet, injection, shot, or nasal spray. Orilissa (elagolix), manufactured by AbbVie Inc., was the first drug given FDA approval to alleviate disease-related pain. Patients who are resistant to the first line of treatment should consider GnRH agonists and antagonists as alternatives.

Regional Outlook

Region wise, the endometriosis market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region dominated the endometriosis market with maximum revenue share in 2021. This is mostly linked to an increase in endometriosis cases, which necessitate additional treatments such as gonadotropin-releasing hormone (GnRH) medications, an increase in government financing for endometriosis research, and a considerable increase in capital income in developed countries. The sophisticated reimbursement structures that exist and are designed to lower expenditure levels also contribute to the market's expansion.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Superficial Peritoneal Lesion
  • Endometriomas
  • Others

By Treatment

  • Oral Contraceptives
  • Gonadotropin-releasing hormone (GnRH) medicines
  • Others

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Teva Pharmaceuticals Industries Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Abbott Laboratories
  • Consilient Health Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Endometriosis Market, by Type
    • 1.4.2 Global Endometriosis Market, by Treatment
    • 1.4.3 Global Endometriosis Market, by Distribution Channel
    • 1.4.4 Global Endometriosis Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Endometriosis Market by Type

  • 3.1 Global Superficial Peritoneal Lesion Market by Region
  • 3.2 Global Endometriomas Market by Region
  • 3.3 Global Others Market by Region

Chapter 4. Global Endometriosis Market by Treatment

  • 4.1 Global Oral Contraceptives Market by Region
  • 4.2 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Endometriosis Market by Distribution Channel

  • 5.1 Global Hospital Pharmacy Market by Region
  • 5.2 Global Retail Pharmacy Market by Region
  • 5.3 Global Online Pharmacy Market by Region

Chapter 6. Global Endometriosis Market by Region

  • 6.1 North America Endometriosis Market
    • 6.1.1 North America Endometriosis Market by Type
      • 6.1.1.1 North America Superficial Peritoneal Lesion Market by Country
      • 6.1.1.2 North America Endometriomas Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Endometriosis Market by Treatment
      • 6.1.2.1 North America Oral Contraceptives Market by Country
      • 6.1.2.2 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.1.2.3 North America Others Market by Country
    • 6.1.3 North America Endometriosis Market by Distribution Channel
      • 6.1.3.1 North America Hospital Pharmacy Market by Country
      • 6.1.3.2 North America Retail Pharmacy Market by Country
      • 6.1.3.3 North America Online Pharmacy Market by Country
    • 6.1.4 North America Endometriosis Market by Country
      • 6.1.4.1 US Endometriosis Market
        • 6.1.4.1.1 US Endometriosis Market by Type
        • 6.1.4.1.2 US Endometriosis Market by Treatment
        • 6.1.4.1.3 US Endometriosis Market by Distribution Channel
      • 6.1.4.2 Canada Endometriosis Market
        • 6.1.4.2.1 Canada Endometriosis Market by Type
        • 6.1.4.2.2 Canada Endometriosis Market by Treatment
        • 6.1.4.2.3 Canada Endometriosis Market by Distribution Channel
      • 6.1.4.3 Mexico Endometriosis Market
        • 6.1.4.3.1 Mexico Endometriosis Market by Type
        • 6.1.4.3.2 Mexico Endometriosis Market by Treatment
        • 6.1.4.3.3 Mexico Endometriosis Market by Distribution Channel
      • 6.1.4.4 Rest of North America Endometriosis Market
        • 6.1.4.4.1 Rest of North America Endometriosis Market by Type
        • 6.1.4.4.2 Rest of North America Endometriosis Market by Treatment
        • 6.1.4.4.3 Rest of North America Endometriosis Market by Distribution Channel
  • 6.2 Europe Endometriosis Market
    • 6.2.1 Europe Endometriosis Market by Type
      • 6.2.1.1 Europe Superficial Peritoneal Lesion Market by Country
      • 6.2.1.2 Europe Endometriomas Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Endometriosis Market by Treatment
      • 6.2.2.1 Europe Oral Contraceptives Market by Country
      • 6.2.2.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.2.2.3 Europe Others Market by Country
    • 6.2.3 Europe Endometriosis Market by Distribution Channel
      • 6.2.3.1 Europe Hospital Pharmacy Market by Country
      • 6.2.3.2 Europe Retail Pharmacy Market by Country
      • 6.2.3.3 Europe Online Pharmacy Market by Country
    • 6.2.4 Europe Endometriosis Market by Country
      • 6.2.4.1 Germany Endometriosis Market
        • 6.2.4.1.1 Germany Endometriosis Market by Type
        • 6.2.4.1.2 Germany Endometriosis Market by Treatment
        • 6.2.4.1.3 Germany Endometriosis Market by Distribution Channel
      • 6.2.4.2 UK Endometriosis Market
        • 6.2.4.2.1 UK Endometriosis Market by Type
        • 6.2.4.2.2 UK Endometriosis Market by Treatment
        • 6.2.4.2.3 UK Endometriosis Market by Distribution Channel
      • 6.2.4.3 France Endometriosis Market
        • 6.2.4.3.1 France Endometriosis Market by Type
        • 6.2.4.3.2 France Endometriosis Market by Treatment
        • 6.2.4.3.3 France Endometriosis Market by Distribution Channel
      • 6.2.4.4 Russia Endometriosis Market
        • 6.2.4.4.1 Russia Endometriosis Market by Type
        • 6.2.4.4.2 Russia Endometriosis Market by Treatment
        • 6.2.4.4.3 Russia Endometriosis Market by Distribution Channel
      • 6.2.4.5 Spain Endometriosis Market
        • 6.2.4.5.1 Spain Endometriosis Market by Type
        • 6.2.4.5.2 Spain Endometriosis Market by Treatment
        • 6.2.4.5.3 Spain Endometriosis Market by Distribution Channel
      • 6.2.4.6 Italy Endometriosis Market
        • 6.2.4.6.1 Italy Endometriosis Market by Type
        • 6.2.4.6.2 Italy Endometriosis Market by Treatment
        • 6.2.4.6.3 Italy Endometriosis Market by Distribution Channel
      • 6.2.4.7 Rest of Europe Endometriosis Market
        • 6.2.4.7.1 Rest of Europe Endometriosis Market by Type
        • 6.2.4.7.2 Rest of Europe Endometriosis Market by Treatment
        • 6.2.4.7.3 Rest of Europe Endometriosis Market by Distribution Channel
  • 6.3 Asia Pacific Endometriosis Market
    • 6.3.1 Asia Pacific Endometriosis Market by Type
      • 6.3.1.1 Asia Pacific Superficial Peritoneal Lesion Market by Country
      • 6.3.1.2 Asia Pacific Endometriomas Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Endometriosis Market by Treatment
      • 6.3.2.1 Asia Pacific Oral Contraceptives Market by Country
      • 6.3.2.2 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.3.2.3 Asia Pacific Others Market by Country
    • 6.3.3 Asia Pacific Endometriosis Market by Distribution Channel
      • 6.3.3.1 Asia Pacific Hospital Pharmacy Market by Country
      • 6.3.3.2 Asia Pacific Retail Pharmacy Market by Country
      • 6.3.3.3 Asia Pacific Online Pharmacy Market by Country
    • 6.3.4 Asia Pacific Endometriosis Market by Country
      • 6.3.4.1 China Endometriosis Market
        • 6.3.4.1.1 China Endometriosis Market by Type
        • 6.3.4.1.2 China Endometriosis Market by Treatment
        • 6.3.4.1.3 China Endometriosis Market by Distribution Channel
      • 6.3.4.2 Japan Endometriosis Market
        • 6.3.4.2.1 Japan Endometriosis Market by Type
        • 6.3.4.2.2 Japan Endometriosis Market by Treatment
        • 6.3.4.2.3 Japan Endometriosis Market by Distribution Channel
      • 6.3.4.3 India Endometriosis Market
        • 6.3.4.3.1 India Endometriosis Market by Type
        • 6.3.4.3.2 India Endometriosis Market by Treatment
        • 6.3.4.3.3 India Endometriosis Market by Distribution Channel
      • 6.3.4.4 South Korea Endometriosis Market
        • 6.3.4.4.1 South Korea Endometriosis Market by Type
        • 6.3.4.4.2 South Korea Endometriosis Market by Treatment
        • 6.3.4.4.3 South Korea Endometriosis Market by Distribution Channel
      • 6.3.4.5 Singapore Endometriosis Market
        • 6.3.4.5.1 Singapore Endometriosis Market by Type
        • 6.3.4.5.2 Singapore Endometriosis Market by Treatment
        • 6.3.4.5.3 Singapore Endometriosis Market by Distribution Channel
      • 6.3.4.6 Malaysia Endometriosis Market
        • 6.3.4.6.1 Malaysia Endometriosis Market by Type
        • 6.3.4.6.2 Malaysia Endometriosis Market by Treatment
        • 6.3.4.6.3 Malaysia Endometriosis Market by Distribution Channel
      • 6.3.4.7 Rest of Asia Pacific Endometriosis Market
        • 6.3.4.7.1 Rest of Asia Pacific Endometriosis Market by Type
        • 6.3.4.7.2 Rest of Asia Pacific Endometriosis Market by Treatment
        • 6.3.4.7.3 Rest of Asia Pacific Endometriosis Market by Distribution Channel
  • 6.4 LAMEA Endometriosis Market
    • 6.4.1 LAMEA Endometriosis Market by Type
      • 6.4.1.1 LAMEA Superficial Peritoneal Lesion Market by Country
      • 6.4.1.2 LAMEA Endometriomas Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Endometriosis Market by Treatment
      • 6.4.2.1 LAMEA Oral Contraceptives Market by Country
      • 6.4.2.2 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country
      • 6.4.2.3 LAMEA Others Market by Country
    • 6.4.3 LAMEA Endometriosis Market by Distribution Channel
      • 6.4.3.1 LAMEA Hospital Pharmacy Market by Country
      • 6.4.3.2 LAMEA Retail Pharmacy Market by Country
      • 6.4.3.3 LAMEA Online Pharmacy Market by Country
    • 6.4.4 LAMEA Endometriosis Market by Country
      • 6.4.4.1 Brazil Endometriosis Market
        • 6.4.4.1.1 Brazil Endometriosis Market by Type
        • 6.4.4.1.2 Brazil Endometriosis Market by Treatment
        • 6.4.4.1.3 Brazil Endometriosis Market by Distribution Channel
      • 6.4.4.2 Argentina Endometriosis Market
        • 6.4.4.2.1 Argentina Endometriosis Market by Type
        • 6.4.4.2.2 Argentina Endometriosis Market by Treatment
        • 6.4.4.2.3 Argentina Endometriosis Market by Distribution Channel
      • 6.4.4.3 UAE Endometriosis Market
        • 6.4.4.3.1 UAE Endometriosis Market by Type
        • 6.4.4.3.2 UAE Endometriosis Market by Treatment
        • 6.4.4.3.3 UAE Endometriosis Market by Distribution Channel
      • 6.4.4.4 Saudi Arabia Endometriosis Market
        • 6.4.4.4.1 Saudi Arabia Endometriosis Market by Type
        • 6.4.4.4.2 Saudi Arabia Endometriosis Market by Treatment
        • 6.4.4.4.3 Saudi Arabia Endometriosis Market by Distribution Channel
      • 6.4.4.5 South Africa Endometriosis Market
        • 6.4.4.5.1 South Africa Endometriosis Market by Type
        • 6.4.4.5.2 South Africa Endometriosis Market by Treatment
        • 6.4.4.5.3 South Africa Endometriosis Market by Distribution Channel
      • 6.4.4.6 Nigeria Endometriosis Market
        • 6.4.4.6.1 Nigeria Endometriosis Market by Type
        • 6.4.4.6.2 Nigeria Endometriosis Market by Treatment
        • 6.4.4.6.3 Nigeria Endometriosis Market by Distribution Channel
      • 6.4.4.7 Rest of LAMEA Endometriosis Market
        • 6.4.4.7.1 Rest of LAMEA Endometriosis Market by Type
        • 6.4.4.7.2 Rest of LAMEA Endometriosis Market by Treatment
        • 6.4.4.7.3 Rest of LAMEA Endometriosis Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 Abbott Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
    • 7.1.5 SWOT Analysis
  • 7.2 Teva Pharmaceutical Industries Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Product Launches and Product Expansions:
  • 7.3 Sun Pharmaceutical Industries Ltd.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
  • 7.4 Sanofi S.A.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
  • 7.5 AbbVie, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Trials and Approvals:
  • 7.6 AstraZeneca PLC
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Regional Analysis
    • 7.6.4 Research & Development Expenses
  • 7.7 Pfizer, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional & Segmental Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Partnerships, Collaborations, and Agreements:
      • 7.7.5.2 Trials and Approvals:
  • 7.8 Merck & Co., Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expenses
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Trials and Approvals:
  • 7.9 GlaxoSmithKline PLC
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Trials and Approvals:
      • 7.9.5.2 Acquisition and Mergers:
  • 7.10. Consilient Health Limited
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 2 Global Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 3 Global Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 4 Global Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 5 Global Superficial Peritoneal Lesion Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Superficial Peritoneal Lesion Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Endometriomas Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Endometriomas Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 12 Global Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 13 Global Oral Contraceptives Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Oral Contraceptives Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Gonadotropin-releasing hormone (GnRH) medicines Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 20 Global Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 21 Global Hospital Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Hospital Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 23 Global Retail Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 24 Global Retail Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 25 Global Online Pharmacy Market by Region, 2018 - 2021, USD Million
  • TABLE 26 Global Online Pharmacy Market by Region, 2022 - 2028, USD Million
  • TABLE 27 Global Endometriosis Market by Region, 2018 - 2021, USD Million
  • TABLE 28 Global Endometriosis Market by Region, 2022 - 2028, USD Million
  • TABLE 29 North America Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 30 North America Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 31 North America Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 32 North America Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 33 North America Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 40 North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 41 North America Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 45 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 48 North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 49 North America Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 55 North America Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 56 North America Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 57 US Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 58 US Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 59 US Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 60 US Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 61 US Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 62 US Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 63 US Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 64 US Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 65 Canada Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 66 Canada Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 67 Canada Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 68 Canada Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 69 Canada Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 70 Canada Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 71 Canada Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 72 Canada Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 73 Mexico Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 74 Mexico Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 75 Mexico Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 76 Mexico Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 77 Mexico Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 78 Mexico Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 79 Mexico Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 80 Mexico Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 81 Rest of North America Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 82 Rest of North America Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 83 Rest of North America Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 84 Rest of North America Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 85 Rest of North America Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 86 Rest of North America Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 87 Rest of North America Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 88 Rest of North America Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 89 Europe Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 90 Europe Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 91 Europe Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 92 Europe Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 93 Europe Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 94 Europe Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 95 Europe Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 96 Europe Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 97 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 98 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 99 Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 100 Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 101 Europe Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 102 Europe Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 103 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 104 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 105 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 106 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 107 Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 108 Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 109 Europe Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 110 Europe Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 111 Europe Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 112 Europe Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 113 Europe Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 114 Europe Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 115 Europe Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 116 Europe Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 117 Germany Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 118 Germany Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 119 Germany Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 120 Germany Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 121 Germany Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 122 Germany Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 123 Germany Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 124 Germany Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 125 UK Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 126 UK Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 127 UK Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 128 UK Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 129 UK Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 130 UK Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 131 UK Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 132 UK Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 133 France Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 134 France Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 135 France Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 136 France Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 137 France Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 138 France Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 139 France Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 140 France Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 141 Russia Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 142 Russia Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 143 Russia Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 144 Russia Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 145 Russia Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 146 Russia Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 147 Russia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 148 Russia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 149 Spain Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 150 Spain Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 151 Spain Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 152 Spain Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 153 Spain Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 154 Spain Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 155 Spain Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 156 Spain Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 157 Italy Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 158 Italy Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 159 Italy Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 160 Italy Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 161 Italy Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 162 Italy Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 163 Italy Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 164 Italy Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 165 Rest of Europe Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 166 Rest of Europe Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 167 Rest of Europe Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 168 Rest of Europe Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 169 Rest of Europe Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 170 Rest of Europe Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 171 Rest of Europe Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 172 Rest of Europe Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 173 Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 174 Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 175 Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 176 Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 177 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 178 Asia Pacific Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 179 Asia Pacific Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 180 Asia Pacific Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 181 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 182 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 183 Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 184 Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 185 Asia Pacific Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 186 Asia Pacific Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 187 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 188 Asia Pacific Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 189 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 190 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 191 Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 192 Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 193 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 194 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 195 Asia Pacific Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 196 Asia Pacific Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 197 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 198 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Asia Pacific Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 200 Asia Pacific Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 201 China Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 202 China Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 203 China Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 204 China Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 205 China Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 206 China Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 207 China Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 208 China Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 209 Japan Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 210 Japan Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 211 Japan Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 212 Japan Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 213 Japan Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 214 Japan Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 215 Japan Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 216 Japan Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 217 India Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 218 India Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 219 India Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 220 India Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 221 India Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 222 India Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 223 India Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 224 India Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 225 South Korea Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 226 South Korea Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 227 South Korea Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 228 South Korea Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 229 South Korea Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 230 South Korea Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 231 South Korea Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 South Korea Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 Singapore Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 234 Singapore Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 235 Singapore Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 236 Singapore Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 237 Singapore Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 238 Singapore Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 239 Singapore Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 240 Singapore Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 241 Malaysia Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 242 Malaysia Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 243 Malaysia Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 244 Malaysia Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 245 Malaysia Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 246 Malaysia Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 247 Malaysia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 248 Malaysia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 249 Rest of Asia Pacific Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 250 Rest of Asia Pacific Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 251 Rest of Asia Pacific Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 252 Rest of Asia Pacific Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 253 Rest of Asia Pacific Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 254 Rest of Asia Pacific Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 255 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 256 Rest of Asia Pacific Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 257 LAMEA Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 258 LAMEA Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 259 LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 260 LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 261 LAMEA Superficial Peritoneal Lesion Market by Country, 2018 - 2021, USD Million
  • TABLE 262 LAMEA Superficial Peritoneal Lesion Market by Country, 2022 - 2028, USD Million
  • TABLE 263 LAMEA Endometriomas Market by Country, 2018 - 2021, USD Million
  • TABLE 264 LAMEA Endometriomas Market by Country, 2022 - 2028, USD Million
  • TABLE 265 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 266 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 267 LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 268 LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 269 LAMEA Oral Contraceptives Market by Country, 2018 - 2021, USD Million
  • TABLE 270 LAMEA Oral Contraceptives Market by Country, 2022 - 2028, USD Million
  • TABLE 271 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2018 - 2021, USD Million
  • TABLE 272 LAMEA Gonadotropin-releasing hormone (GnRH) medicines Market by Country, 2022 - 2028, USD Million
  • TABLE 273 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 274 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 275 LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 276 LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 277 LAMEA Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 278 LAMEA Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 279 LAMEA Retail Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 280 LAMEA Retail Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 281 LAMEA Online Pharmacy Market by Country, 2018 - 2021, USD Million
  • TABLE 282 LAMEA Online Pharmacy Market by Country, 2022 - 2028, USD Million
  • TABLE 283 LAMEA Endometriosis Market by Country, 2018 - 2021, USD Million
  • TABLE 284 LAMEA Endometriosis Market by Country, 2022 - 2028, USD Million
  • TABLE 285 Brazil Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 286 Brazil Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 287 Brazil Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 288 Brazil Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 289 Brazil Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 290 Brazil Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 291 Brazil Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 292 Brazil Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 293 Argentina Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 294 Argentina Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 295 Argentina Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 296 Argentina Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 297 Argentina Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 298 Argentina Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 299 Argentina Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 300 Argentina Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 301 UAE Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 302 UAE Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 303 UAE Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 304 UAE Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 305 UAE Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 306 UAE Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 307 UAE Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 308 UAE Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 309 Saudi Arabia Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 310 Saudi Arabia Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 311 Saudi Arabia Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 312 Saudi Arabia Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 313 Saudi Arabia Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 314 Saudi Arabia Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 315 Saudi Arabia Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 316 Saudi Arabia Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 317 South Africa Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 318 South Africa Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 319 South Africa Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 320 South Africa Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 321 South Africa Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 322 South Africa Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 323 South Africa Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 324 South Africa Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 325 Nigeria Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 326 Nigeria Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 327 Nigeria Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 328 Nigeria Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 329 Nigeria Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 330 Nigeria Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 331 Nigeria Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 332 Nigeria Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 333 Rest of LAMEA Endometriosis Market, 2018 - 2021, USD Million
  • TABLE 334 Rest of LAMEA Endometriosis Market, 2022 - 2028, USD Million
  • TABLE 335 Rest of LAMEA Endometriosis Market by Type, 2018 - 2021, USD Million
  • TABLE 336 Rest of LAMEA Endometriosis Market by Type, 2022 - 2028, USD Million
  • TABLE 337 Rest of LAMEA Endometriosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 338 Rest of LAMEA Endometriosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 339 Rest of LAMEA Endometriosis Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 340 Rest of LAMEA Endometriosis Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 341 Key Information - Abbott Laboratories
  • TABLE 342 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 343 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 344 Key Information - Sanofi S.A.
  • TABLE 345 Key information - AbbVie, Inc.
  • TABLE 346 KEY INFORMATION - AstraZeneca PLC
  • TABLE 347 Key Information - Pfizer, Inc.
  • TABLE 348 KEY INFORMATION - Merck & Co., Inc.
  • TABLE 349 Key Information - GlaxoSmithKline PLC
  • TABLE 350 Key Information - Consilient Health Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Endometriosis Market share by Type, 2021
  • FIG 3 Global Endometriosis Market share by Type, 2028
  • FIG 4 Global Endometriosis Market by Type, 2018 - 2028, USD Million
  • FIG 5 Global Endometriosis Market share by Treatment, 2021
  • FIG 6 Global Endometriosis Market share by Treatment, 2028
  • FIG 7 Global Endometriosis Market by Treatment, 2018 - 2028, USD Million
  • FIG 8 Global Endometriosis Market share by Distribution Channel, 2021
  • FIG 9 Global Endometriosis Market share by Distribution Channel, 2028
  • FIG 10 Global Endometriosis Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 11 Global Endometriosis Market share by Region, 2021
  • FIG 12 Global Endometriosis Market share by Region, 2028
  • FIG 13 Global Endometriosis Market by Region, 2018 - 2028, USD Million
  • FIG 14 Swot analysis: Abbott laboratories